Abstract:Antibiotic selection for the maintenance of expression plasmids is discouraged in the production of recombinant proteins for pharmaceutical or other human uses due to the risks of antibiotic residue contamination of the final products and the release of DNA encoding antibiotic resistance into the environment. We describe the construction of expression plasmids that are instead maintained by complementation of the lgt gene encoding a (pro)lipoprotein glyceryl transferase essential for the biosynthesis of bacterial lipoprotein. Mutations in lgt are lethal in Escherichia coli and other Gram-negative organisms. The lgt gene was deleted from E. coli and complemented by the Vibrio cholerae-derived gene provided in trans on a temperature-sensitive plasmid, allowing cells to grow at 30°C but not at 37°C. A temperature-insensitive expression vector carrying the V. cholerae-derived lgt gene was constructed, whereby transformants were selected by growth at 39°C. The vector was successfully used to express two recombinant proteins, one soluble and one forming insoluble inclusion bodies. Reciprocal construction was done by deleting the lgt gene from V. cholerae and complementing the lesion with the corresponding gene from E. coli The resulting strain was used to produce the secreted recombinant cholera toxin B subunit (CTB) protein, a component of licensed as well as newly developed oral cholera vaccines. Overall, the lgt system described here confers extreme stability on expression plasmids, and this strategy can be easily transferred to other Gram-negative species using the E. coli-derived lgt gene for complementation.IMPORTANCE Many recombinant proteins are produced in bacteria from genes carried on autonomously replicating DNA elements called plasmids. These plasmids are usually inherently unstable and rapidly lost. This can be prevented by using genes encoding antibiotic resistance. Plasmids are thus maintained by allowing only plasmid-containing cells to survive when the bacteria are grown in medium supplemented with antibiotics. In the described antibiotic-free system for the production of recombinant proteins, an essential gene is deleted from the bacterial chromosome and instead provided on a plasmid. The loss of the plasmid becomes lethal for the bacteria. Such plasmids can be used for the expression of recombinant proteins. This broadly applicable system removes the need for antibiotics in recombinant protein production, thereby contributing to reducing the spread of genes encoding antibiotic resistance, reducing the release of antibiotics into the environment, and freeing the final products (often used in pharmaceuticals) from contamination with potentially harmful antibiotic residues.

Recombinant expression plasmid as well as preparation method and application thereof

Construction of a low molecular weight plasmid vector for the capture of genes encoding exported proteins.

Constructing Prokaryotic Vector of BC047440 Gene Expression and Purification of Its Recombinant Protein

Improved, two-stage protein expression and purification via autoinduction of both autolysis and auto DNA/RNA hydrolysis conferred by phage lysozyme and DNA/RNA endonuclease

Method for recombining plasmid expression system to Escherichia coli chromosome through optimization

Cytokinetic engineering enhances the secretory production of recombinant human lysozyme in Komagataella phaffii

High-level Expression,Purification and Activity of the Plectasin

Construction of the eukaryotic expression plasmid compatible with the detection system of shuttle plasmid pZ189

Expression and Properties of a Bacillus Licheniformis Lipasein Bacillus Subtilis

[Expression of hemolytic phospholipase C from Pseudomonas aeruginosa in Escherichia coli].

Cloning and Heterologous Expression in E.coli of Phospholipase C Gene from Bacillus Cereus

Exploiting Systematic Engineering of the Expression Cassette as a Powerful Tool to Enhance Heterologous Gene Expression in Trichoderma reesei.

Simultaneous Expression of Glutaryl-7-aminocephalosporanic Acid Acylase Gene and Lysis Genes of Phage Λ in a Recombinant E. Coli

Efficient Molecular Biological Manipulations with Improved Strategies Based on Novel Escherichia Coli Vectors.

Controllable Autolytic Leaky E. coli Platform for the Recovery of Intracellular Proteins

A Novel Nonantibiotic, lgt-Based Selection System for Stable Maintenance of Expression Vectors in Escherichia coli and Vibrio cholerae

Improving Photocleavage Efficiency of Photocleavable Protein for Antimicrobial Peptide Histatin 1 Expression

Flow-cytometric cell sorting coupled with UV mutagenesis for improving pectin lyase expression

Whole-cell biocatalysis for ε-poly-l-lysine production by a food-grade recombinant Bacillus subtilis

A Continuous Process to Extract Plasmid DNA Based on Alkaline Lysis

Plasmid DNA production combining antibiotic-free selection, inducible high yield fermentation, and novel autolytic purification